The CDKN2A locus : mechanisms of tumour supression
Malignant melanoma currently accounts for four percent of newly diagnosed cancers in the UK. The genetic alterations that bring about melanoma are not fully understood, but several genes and pathways have been implicated. Following oncogenic activation, somatic cells undergo an irreversible cessatio...
Main Author: | Kallenberg, David Marc |
---|---|
Published: |
St George's, University of London
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656854 |
Similar Items
-
Circulating tumour cells and biomarkers in neuroendocrine tumours
by: Khan, M. S.
Published: (2013) -
Importance of the tumour microenvironment in the treatment response of prostate tumours
by: Byrne, Niall Maurice
Published: (2014) -
Mechanisms involved in breast tumour cell mediated bone resorption in vitro
by: Morgan, Hayley Michaela
Published: (2000) -
Screening for novel brain tumour initiation mechanisms at single cell resolution
by: Jaworek, Karolina
Published: (2016) -
Studies of the Wilms' tumour 1 gene in patients with solid tumours
by: Gillmore, Roopinder
Published: (2006)